Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Meta-Analysis.

CONCLUSION: The pooled analysis demonstrates that anti-TNF-α agents have the same efficacy as novel agents (ustekinumab, secukinumab, and ixekizumab) in dactylitis and enthesitis.
PMID: 30824641 [PubMed - as supplied by publisher]

Source: Journal of Rheumatology - March 4, 2019 Category: Rheumatology Tags: J Rheumatol Source Type: research